Ewing, New Jersey-based Church & Dwight Co., Inc. (CHD) develops, manufactures, and markets household, personal care, and specialty products. Valued at $22.6 billion by market cap, Church & Dwight operates through Consumer Domestic, Consumer International, and Specialty Products segments.

Church & Dwight has significantly underperformed the broader market over the past year and in 2025. CHD stock prices have dropped 6.1% over the past 52 weeks and 10.2% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 14.3% gains over the past year and 9% returns in 2025.

Narrowing the focus, CHD has also lagged behind the sector-focused Consumer Staples Select Sector SPDR Fund’s (XLP) 2.4% gains over the past year and 5.3% uptick in 2025.

Church & Dwight’s stock prices observed a marginal uptick in the trading session following the release of its better-than-expected Q2 results on Aug. 1. The company observed an 80 bps increase in organic volumes, but sales were negatively impacted by an unfavorable pricing mix. Overall, its organic sales inched up by 10 bps, while total topline dipped by 32 bps year-over-year to $1.5 billion, but surpassed the consensus estimates by 1.8%. Meanwhile, its adjusted EPS grew by a modest 1.1% year-over-year to $0.94, exceeding the Street expectations by 10.6%.

For the full fiscal 2025, ending in December, analysts expect CHD to deliver an adjusted EPS of $3.47, up 87 bps year-over-year. On the positive note, the company has a solid earnings surprise history. It has met or surpassed the Street’s bottom-line estimates in each of the past four quarters.

The stock has a consensus “Moderate Buy” rating overall. Of the 22 analysts covering the CHD stock, opinions include nine “Strong Buys,” one “Moderate Buy,” eight “Holds,” and four “Strong Sells.”

This configuration is slightly less optimistic than three months ago, when 10 analysts gave “Strong Buy” recommendations and only three analysts gave “Strong Sell” suggestions.

On Aug. 4, Evercore ISI Group analyst Javier Escalante reiterated an “In-Line” rating on CHD and lowered the price target from $102 to $101.

As of writing, CHD’s mean price target of $102.22 represents an 8.7% premium to current price levels. Meanwhile, the street-high target of $120 suggests a notable 27.6% upside potential.